Inventor · disambiguated record
Israel Nur
Also filed as: NUR ISRAEL
64 granted patents·17 pending applications·5,300 citations·filing 1996–2024
98Inventor score
Files withOMRIX BIOPHARMACEUTICALS LTD38NUR ISRAEL8OMRIX BIOPHARMACEUTICALS INC4OPPERBAS HOLDING BV4ILAN EREZ2
Top patents by PatentIndex Score
81 records- 0198US8857694B2Staple cartridge loading assemblySHELTON IV FREDERICK E·Filed 2011·Granted Oct 14, 2014·1.5k cites·13 claims
- 0298US8814025B2Fibrin pad matrix with suspended heat activated beads of adhesiveMILLER MATTHEW C·Filed 2011·Granted Aug 26, 2014·1.7k cites·20 claims
- 0396US7125569B2Removal of plasmin(ogen) from protein solutionsOMRIX BIOPHARMACEUTICALS INC·Filed 2002·Granted Oct 24, 2006·83 cites·8 claims
- 0495US8899464B2Attachment of surgical staple buttress to cartridgeHUEIL GEOFFREY C·Filed 2011·Granted Dec 2, 2014·1.6k cites·20 claims
- 0588US8354249B2Intravenous immunoglobulin compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2005·Granted Jan 15, 2013·13 cites·20 claims
- 0687US7641918B2Plasma cryoprecipitate substantially free of plasminogenOMRIX BIOPHARMACEUTICALS INC·Filed 2006·Granted Jan 5, 2010·6 cites·4 claims
- 0787US2024376459A1Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0886US8322637B2Method of micronizationNUR ISRAEL·Filed 2007·Granted Dec 4, 2012·4 cites·17 claims
- 0984US9125906B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsBUENSUCESO CHARITO S·Filed 2011·Granted Sep 8, 2015·9 cites·28 claims
- 1083US9585918B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsDEPUY SYNTHES PRODUCTS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
- 1183US6468733B2Method of the inactivation of viruses by a solvent-detergent combination and nanofiltrationOMRIX BIOPHARMACEUTICALS INC·Filed 2001·Granted Oct 22, 2002·42 cites·10 claims
- 1282US9439997B2Reinforced absorbable multilayered hemostatis wound dressingGORMAN ANNE JESSICA·Filed 2006·Granted Sep 13, 2016·4 cites·9 claims
- 1382US6121232AStabilized mixture comprising fibrinogenOMRIX BIOPHARM SA·Filed 1997·Granted Sep 19, 2000·95 cites·14 claims
- 1481US9365635B2Intravenous immunoglobulin compositionNUR ISRAEL·Filed 2012·Granted Jun 14, 2016·3 cites·5 claims
- 1581US8475812B2Gelatin sponge comprising an active ingredient, its preparation and useNUR ISRAEL·Filed 2009·Granted Jul 2, 2013·6 cites·15 claims
- 1680US6930087B2Pharmaceutical composition comprising factor VIII and neutral liposomesOPPERBAS HOLDING BV·Filed 2002·Granted Aug 16, 2005·10 cites·17 claims
- 1778US9814765B2One component fibrin glue comprising zymogensOMRIX BIOPHARMACEUTICALS LTD·Filed 2014·Granted Nov 14, 2017·3 cites·32 claims
- 1877US12351843B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jul 8, 2025·0 cites·4 claims
- 1976US9328338B2Method for removing a lytic enzyme from a heterogeneous mixtureMEIDLER ROBERTO·Filed 2012·Granted May 3, 2016·5 cites·15 claims
- 2076US8962033B2Method for improved fibrin sealingILAN EREZ·Filed 2011·Granted Feb 24, 2015·6 cites·21 claims
- 2175US8603541B2Viral inactivated platelet extract, use and preparation thereofWEISSMAN LIOR·Filed 2011·Granted Dec 10, 2013·5 cites·14 claims
- 2275US6207456B1Nucleic acid delivery vehicleOPPERBAS HOLDING BV·Filed 1996·Granted Mar 27, 2001·46 cites·6 claims
- 2374US11149263B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Oct 19, 2021·0 cites·4 claims
- 2474US8563288B2Removal of plasmin or plasminogen from cryoprecipitateNUR ISRAEL·Filed 2008·Granted Oct 22, 2013·2 cites·16 claims
- 2574US6593294B1Pharmaceutical composition comprising Factor VIII and neutral liposomesOPPERBAS HOLDING BV·Filed 1999·Granted Jul 15, 2003·36 cites·17 claims
- 2673US11993797B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 2773US11583573B2High concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Feb 21, 2023·0 cites·5 claims
- 2873US10357589B2One component fibrin glue comprising a polymerization inhibitorOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Granted Jul 23, 2019·1 cites·3 claims
- 2972US2023158119A1High concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 3070US11918629B2Low concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Mar 5, 2024·0 cites·11 claims
- 3170US9867852B2Viral inactivated biological mixtureOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Jan 16, 2018·2 cites·22 claims
- 3270US9278181B2Devices for injecting a substance and methods thereforMERON MOTI·Filed 2011·Granted Mar 8, 2016·6 cites·21 claims
- 3370US6156337AMethod for high loading of vesicles with biopolymeric substancesOPPERBAS HOLDING BV·Filed 1996·Granted Dec 5, 2000·40 cites·36 claims
- 3469US11938165B2Stable pharmaceutical foamOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Mar 26, 2024·0 cites·1 claims
- 3569US11225652B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Jan 18, 2022·0 cites·12 claims
- 3669US9023994B2Immunoglobulin reduced in thrombogenic agents and preparation thereofMINTZ RONI·Filed 2012·Granted May 5, 2015·2 cites·14 claims
- 3769US8981058B2Gelatin sponge comprising an active ingredient, its preparation and useNUR ISRAEL·Filed 2013·Granted Mar 17, 2015·1 cites·7 claims
- 3868US9943546B2Viral inactivated platelet extract, use and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Apr 17, 2018·1 cites·11 claims
- 3968US8968724B2Compositions suitable for treatment of spinal disease, disorder or conditionBECHOR EDNA·Filed 2008·Granted Mar 3, 2015·2 cites·11 claims
- 4067US11008560B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 4166US10039865B2Implantable device comprising a substrate pre-coated with stabilized fibrinSHEETRIT EYAL·Filed 2009·Granted Aug 7, 2018·1 cites·9 claims
- 4266US9213035B2Protein assayDE ANGLIS ASHLEY·Filed 2008·Granted Dec 15, 2015·3 cites·25 claims
- 4366US8640921B2Device, system and method for dispensing a fixed dose of fluidMERON MOTI·Filed 2011·Granted Feb 4, 2014·6 cites·27 claims
- 4465US9212357B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 4564US10479987B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Nov 19, 2019·0 cites·9 claims
- 4664US6916911B1Use of fibrinogen multimersOMRIX BIOPHARM SA·Filed 2000·Granted Jul 12, 2005·14 cites·7 claims
- 4763US11123397B2Stable pharmaceutical foamOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Granted Sep 21, 2021·0 cites·7 claims
- 4863US10538754B2Method for preparation of thrombinOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Jan 21, 2020·1 cites·18 claims
- 4961US8450067B2Method for obtaining anti-idiotype antibodiesNUR ISRAEL·Filed 2003·Granted May 28, 2013·1 cites·12 claims
- 5060US9896716B2Protein assayOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Feb 20, 2018·0 cites·3 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Israel Nur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →